Dr Robert Mchenry Bauer, MD, PHD | |
301 Bowman Gray Dr, Greenville, NC 27834-7204 | |
(252) 758-5800 | |
(252) 758-3508 |
Full Name | Dr Robert Mchenry Bauer |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 26 Years |
Location | 301 Bowman Gray Dr, Greenville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366432924 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 0101102703 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vidant Medical Center | Greenville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
White Eye Associates Pa | 3173557964 | 5 |
News Archive
Neuropathic pain is the chronic, pathological pain that continues even when the cause of pain is removed. Causes include damage to nerve cells and medicines used to treat cancer.
ACIST Medical Systems, Inc., a Bracco Group Company, today announced the global launch of its ACIST RXi Mini System, the next generation system of its RXi Rapid Exchange FFR System. The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics scientific symposium in Denver, Colorado.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).
› Verified 5 days ago
Entity Name | White Eye Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366557803 PECOS PAC ID: 3173557964 Enrollment ID: O20070220000334 |
News Archive
Neuropathic pain is the chronic, pathological pain that continues even when the cause of pain is removed. Causes include damage to nerve cells and medicines used to treat cancer.
ACIST Medical Systems, Inc., a Bracco Group Company, today announced the global launch of its ACIST RXi Mini System, the next generation system of its RXi Rapid Exchange FFR System. The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics scientific symposium in Denver, Colorado.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert Mchenry Bauer, MD, PHD 301 Bowman Gray Dr, Greenville, NC 27834-7204 Ph: (252) 758-5800 | Dr Robert Mchenry Bauer, MD, PHD 301 Bowman Gray Dr, Greenville, NC 27834-7204 Ph: (252) 758-5800 |
News Archive
Neuropathic pain is the chronic, pathological pain that continues even when the cause of pain is removed. Causes include damage to nerve cells and medicines used to treat cancer.
ACIST Medical Systems, Inc., a Bracco Group Company, today announced the global launch of its ACIST RXi Mini System, the next generation system of its RXi Rapid Exchange FFR System. The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics scientific symposium in Denver, Colorado.
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).
› Verified 5 days ago
Mrs. Catherine S Steffee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2425 Hemby Ln, Greenville, NC 27834 Phone: 252-758-4166 Fax: 252-758-5456 | |
Dr. Jeffrey J Viscardi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 301 Bowman Gray Dr, Greenville, NC 27834 Phone: 252-758-5800 Fax: 252-758-3226 | |
Dr. Veda J Moore, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 301 Bowman Gray Dr, Greenville, NC 27834 Phone: 252-758-5800 Fax: 252-758-3226 | |
Peter Arthur Van Houten, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2501 Stantonsburg Rd Ste A, Greenville, NC 27834 Phone: 252-758-2402 Fax: 252-758-2762 | |
Dr. Ann Ostrovsky, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9 Medical Dr, Greenville, NC 27834 Phone: 252-847-5425 | |
Dr. Charles William Titone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1011 Wh Smith Blvd, Suite 108, Greenville, NC 27834 Phone: 252-355-7301 Fax: 252-364-3140 |